Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2020-2024

Published by TechNavio (Infiniti Research Ltd.) Product code 970195
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2020-2024
Published: October 15, 2020 Content info: 120 Pages
Description

Global HIV rapid test kits market 2020-2024

Technavio has been monitoring the HIV rapid test kits market and it is poised to grow by $ 226.64 mn during 2020-2024 progressing at a CAGR of 6% during the forecast period. Our reports on HIV rapid test kits market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing demand for point-of-care testing for HIV, rise in awareness programs for HIV testing and high prevalence of HIV. In addition, growing demand for point-of-care testing for HIV is anticipated to boost the growth of the market as well.

The HIV rapid test kits market analysis includes end-user segment and geographical landscapes

Technavio's HIV rapid test kits market is segmented as below:

By End-user

  • Diagnostic centers
  • Hospitals and clinics

By Geographic Landscapes

  • North America
  • Europe
  • Asia
  • ROW

This study identifies availability of a broad range of HIV rapid test kits by vendors as one of the prime reasons driving the HIV rapid test kits market growth during the next few years. Also, efforts to increase pre-marital screenings for HIV and increasing clinical studies by researchers and promotional activities by manufacturers will lead to sizable demand in the market.

"Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our HIV rapid test kits market covers the following areas:

  • HIV rapid test kits market sizing
  • HIV rapid test kits market forecast
  • HIV rapid test kits market industry analysis"

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading HIV rapid test kits market vendors that include Abbott Laboratories, Becton, Dickinson and Co., bioMA©rieux SA, Bio-Rad Laboratories Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., Hologic Inc., Nectar Lifesciences Ltd., QIAGEN NV, and Trinity Biotech Plc. Also, the HIV rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR45322

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five Forces Summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End user
  • Diagnostic centers - Market size and forecast 2019-2024
  • Hospitals and clinics - Market size and forecast 2019-2024
  • Market opportunity by End user

Market Segmentation by Type

  • Market segments
  • Comparison by Type
  • HIV rapid immunoassay test - Market size and forecast 2019-2024
  • HIV rapid molecular diagnostic test - Market size and forecast 2019-2024
  • Market opportunity by Type

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Volume drivers - Demand led growth
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Vendor landscape
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • Danaher Corp.
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Nectar Lifesciences Ltd.
  • QIAGEN NV
  • Trinity Biotech Plc

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Key Finding 9
  • 9: Parent market
  • 10: Market characteristics
  • 11: Offerings of vendors included in the market definition
  • 12: Market segments
  • 13: Global - Market size and forecast 2019 - 2024 ($ million)
  • 14: Global market: Year-over-year growth 2019 - 2024 (%)
  • 15: Five forces analysis 2019 & 2024
  • 16: Bargaining power of buyers
  • 17: Bargaining power of suppliers
  • 18: Threat of new entrants
  • 19: Threat of substitutes
  • 20: Threat of rivalry
  • 21: Market condition - Five forces 2019
  • 22: End user - Market share 2019-2024 (%)
  • 23: Comparison by End user
  • 24: Diagnostic centers - Market size and forecast 2019-2024 ($ million)
  • 25: Diagnostic centers - Year-over-year growth 2019-2024 (%)
  • 26: Hospitals and clinics - Market size and forecast 2019-2024 ($ million)
  • 27: Hospitals and clinics - Year-over-year growth 2019-2024 (%)
  • 28: Market opportunity by End user
  • 29: Type - Market share 2019-2024 (%)
  • 30: Comparison by Type
  • 31: HIV rapid immunoassay test - Market size and forecast 2019-2024 ($ million)
  • 32: HIV rapid immunoassay test - Year-over-year growth 2019-2024 (%)
  • 33: HIV rapid molecular diagnostic test - Market size and forecast 2019-2024 ($ million)
  • 34: HIV rapid molecular diagnostic test - Year-over-year growth 2019-2024 (%)
  • 35: Market opportunity by Type
  • 36: Customer landscape
  • 37: Market share by geography 2019-2024 (%)
  • 38: Geographic comparison
  • 39: North America - Market size and forecast 2019-2024 ($ million)
  • 40: North America - Year-over-year growth 2019-2024 (%)
  • 41: Europe - Market size and forecast 2019-2024 ($ million)
  • 42: Europe - Year-over-year growth 2019-2024 (%)
  • 43: Asia - Market size and forecast 2019-2024 ($ million)
  • 44: Asia - Year-over-year growth 2019-2024 (%)
  • 45: ROW - Market size and forecast 2019-2024 ($ million)
  • 46: ROW - Year-over-year growth 2019-2024 (%)
  • 47: Key leading countries
  • 48: Market opportunity by geography ($ million)
  • 49: Impact of drivers and challenges
  • 50: Vendor landscape
  • 51: Landscape disruption
  • 52: Industry risks
  • 53: Vendors covered
  • 54: Market positioning of vendors
  • 55: Abbott Laboratories - Overview
  • 56: Abbott Laboratories - Business segments
  • 57: Abbott Laboratories - Key offerings
  • 58: Abbott Laboratories - Key customers
  • 59: Abbott Laboratories - Segment focus
  • 60: Becton, Dickinson and Co. - Overview
  • 61: Becton, Dickinson and Co. - Business segments
  • 62: Becton, Dickinson and Co. - Key offerings
  • 63: Becton, Dickinson and Co. - Key customers
  • 64: Becton, Dickinson and Co. - Segment focus
  • 65: bioMerieux SA - Overview
  • 66: bioMerieux SA - Business segments
  • 67: bioMerieux SA - Key offerings
  • 68: bioMerieux SA - Key customers
  • 69: bioMerieux SA - Segment focus
  • 70: Bio-Rad Laboratories Inc. - Overview
  • 71: Bio-Rad Laboratories Inc. - Business segments
  • 72: Bio-Rad Laboratories Inc. - Key offerings
  • 73: Bio-Rad Laboratories Inc. - Key customers
  • 74: Bio-Rad Laboratories Inc. - Segment focus
  • 75: Danaher Corp. - Overview
  • 76: Danaher Corp. - Business segments
  • 77: Danaher Corp. - Key offerings
  • 78: Danaher Corp. - Key customers
  • 79: Danaher Corp. - Segment focus
  • 80: F. Hoffmann-La Roche Ltd. - Overview
  • 81: F. Hoffmann-La Roche Ltd. - Business segments
  • 82: F. Hoffmann-La Roche Ltd. - Key offerings
  • 83: F. Hoffmann-La Roche Ltd. - Key customers
  • 84: F. Hoffmann-La Roche Ltd. - Segment focus
  • 85: Hologic Inc. - Overview
  • 86: Hologic Inc. - Business segments
  • 87: Hologic Inc. - Key offerings
  • 88: Hologic Inc. - Key customers
  • 89: Hologic Inc. - Segment focus
  • 90: Nectar Lifesciences Ltd. - Overview
  • 91: Nectar Lifesciences Ltd. - Business segments
  • 92: Nectar Lifesciences Ltd. - Key offerings
  • 93: Nectar Lifesciences Ltd. - Key customers
  • 94: Nectar Lifesciences Ltd. - Segment focus
  • 95: QIAGEN NV - Overview
  • 96: QIAGEN NV - Business segments
  • 97: QIAGEN NV - Key offerings
  • 98: QIAGEN NV - Key customers
  • 99: QIAGEN NV - Segment focus
  • 100: Trinity Biotech Plc - Overview
  • 101: Trinity Biotech Plc - Product and service
  • 102: Trinity Biotech Plc - Key offerings
  • 103: Trinity Biotech Plc - Key customers
  • 104: Trinity Biotech Plc - Segment focus
  • 105: Currency conversion rates for US$
  • 106: Research Methodology
  • 107: Validation techniques employed for market sizing
  • 108: Information sources
  • 109: List of abbreviations
Back to Top